Immune thrombocytopenia induced by nivolumab in a patient with non-small cell lung cancer

Antibodies targeting the receptor programmed death 1 on T cells have been approved for the treatment of lung cancer. Immune checkpoint inhibitors (ICIs) induce various immune-related adverse events. Life-threatening hematotoxicity can be provoked by ICI therapy. Although ICI-related endocrinopathy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Hidenori, Sakai, Chizuru, Iwai, Masamichi, Sasaki, Yuka, Gomyo, Takenobu, Toyoshi, Sayaka, Kaito, Daizo, Yanase, Komei, Ito, Fumitaka, Endo, Junki, Funaguchi, Norihiko, Ohno, Yasushi, Minatoguchi, Shinya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557745/
https://www.ncbi.nlm.nih.gov/pubmed/31198679
http://dx.doi.org/10.1016/j.rmcr.2019.100871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557745/
https://www.ncbi.nlm.nih.gov/pubmed/31198679
http://dx.doi.org/10.1016/j.rmcr.2019.100871

Ejemplares similares